Citadel Advisors LLC
- SEC CIK
- 0001423053
- Latest filing
- Sep 1, 2026
ATNM holding history
Actinium Pharmaceuticals, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATNM overviewAll 13F holders of ATNMFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −126,615−100.0% | Sold out | Holders |
| Q3 2025 | 126,615 | $202.6K | <0.1% | +71,609+130.2% | Added | Holders |
| Q2 2025 | 55,006 | $77.0K | <0.1% | +55,006 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −298−100.0% | Sold out | Holders |
| Q4 2024 | 298 | $375 | <0.1% | +275+1,195.7% | Added | Holders |
| Q3 2024 | 23 | $43 | <0.1% | −65,454−100.0% | Reduced | Holders |
| Q2 2024 | 65,477 | $484.5K | <0.1% | −42,638−39.4% | Reduced | Holders |
| Q1 2024 | 108,115 | $846.5K | <0.1% | +75,707+233.6% | Added | Holders |
| Q4 2023 | 32,408 | $164.6K | <0.1% | −36,682−53.1% | Reduced | Holders |
| Q3 2023 | 69,090 | $409.0K | <0.1% | −102,980−59.8% | Reduced | Holders |
| Q2 2023 | 172,070 | $1.28M | <0.1% | +103,136+149.6% | Added | Holders |
| Q1 2023 | 68,934 | $651.4K | <0.1% | −52,488−43.2% | Reduced | Holders |
| Q4 2022 | 121,422 | $1.29M | <0.1% | +80,314+195.4% | Added | Holders |
| Q3 2022 | 41,108 | $303.0K | <0.1% | −12,360−23.1% | Reduced | Holders |
| Q2 2022 | 53,468 | $257.0K | <0.1% | +28,798+116.7% | Added | Holders |
| Q1 2022 | 24,670 | $126.0K | <0.1% | +24,670 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −11,001−100.0% | Sold out | Holders |
| Q3 2021 | 11,001 | $98.0K | <0.1% | +11,001 | New | Holders |